Moderna’s COVID-19 vaccine candidate moves into late-stage trial - The Indian Express 28-Jul-2020

Moderna’s COVID-19 vaccine candidate moves into late-stage trial - The Indian Express

Moderna said it remains on track to deliver about 500 million doses a year, and possibly up to 1 billion doses a year, beginning 2021.